Hasil Pencarian - Sigrid K. Brækkan

Perbaiki Hasil
  1. 1
    VTE epidemiology and challenges for VTE prevention at the population level

    VTE epidemiology and challenges for VTE prevention at the population level oleh Sigrid K. Brækkan, John-Bjarne Hansen

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Weight Change and Risk of Venous Thromboembolism: The Tromsø Study.

    Weight Change and Risk of Venous Thromboembolism: The Tromsø Study. oleh Lars Daae Horvei, Sigrid K Brækkan, John-Bjarne Hansen

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Role of microRNAs in Venous Thromboembolism

    Role of microRNAs in Venous Thromboembolism oleh Vânia M. Morelli, Sigrid K. Brækkan, John-Bjarne Hansen

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study.

    White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study. oleh Kristine Blix, Hilde Jensvoll, Sigrid K Brækkan, John-Bjarne Hansen

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.

    Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study. oleh Hilde Jensvoll, Kristine Blix, Sigrid K Brækkan, John-Bjarne Hansen

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study

    Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study oleh Dana Meknas, Sigrid K. Brækkan, John-Bjarne Hansen, Vânia M. Morelli

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Platelet count and risk of major bleeding in venous thromboembolism

    Platelet count and risk of major bleeding in venous thromboembolism oleh Håkon S. Johnsen, Sigrid K. Braekkan, Vânia M. Morelli, John-Bjarne Hansen

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study

    Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients – the Tromsø Study oleh Trygve S. Ellingsen, Jostein Lappegård, Tove Skjelbakken, Sigrid K. Brækkan, John-Bjarne Hansen

    Diterbitkan 2015-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    D-dimer measured at first venous thromboembolism is associated with future risk of cancer

    D-dimer measured at first venous thromboembolism is associated with future risk of cancer oleh Olga V. Gran, Sigrid K. Brækkan, Benedikte Paulsen, Hanne Skille, John-Bjarne Hansen

    Diterbitkan 2016-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function – the Tromsø study

    Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function – the Tromsø study oleh Ellen E. Brodin, Sigrid K. Brækkan, Anders Vik, Jan Brox, John-Bjarne Hansen

    Diterbitkan 2012-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Hematocrit and risk of venous thromboembolism in a general population. The Tromsø study

    Hematocrit and risk of venous thromboembolism in a general population. The Tromsø study oleh Sigrid K. Brækkan, Ellisiv B. Mathiesen, Inger Njølstad, Tom Wilsgaard, John-Bjarne Hansen

    Diterbitkan 2010-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study

    Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study oleh Gro Grimnes, Lars D. Horvei, Vladimir Tichelaar, Sigrid K. Brækkan, John-Bjarne Hansen

    Diterbitkan 2016-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Plasma hepcidin is associated with future risk of venous thromboembolism

    Plasma hepcidin is associated with future risk of venous thromboembolism oleh Trygve S. Ellingsen, Jostein Lappegård, Thor Ueland, Pål Aukrust, Sigrid K. Brækkan, John-Bjarne Hansen

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study

    Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study oleh Stein Harald Johnsen, Bjarne K. Jacobsen, Sigrid K. Brækkan, John-Bjarne Hansen, Ellisiv B. Mathiesen

    Diterbitkan 2018-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study

    Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study oleh Trond Børvik, Line H. Evensen, Vania M. Morelli, Hasse Melbye, Sigrid K. Brækkan, John‐Bjarne Hansen

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Hand grip strength and risk of incident venous thromboembolism: The Tromsø study

    Hand grip strength and risk of incident venous thromboembolism: The Tromsø study oleh Oda G. R. Leknessund, Vania M. Morelli, Bjørn Heine Strand, John‐Bjarne Hansen, Sigrid K. Brækkan

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding

    D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding oleh Håkon S. Johnsen, Kristian Hindberg, Esben Bjøri, Ellen E. Brodin, Sigrid K. Brækkan, Vânia M. Morelli, John-Bjarne Hansen

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Plasma procoagulant phospholipid clotting time and venous thromboembolism risk

    Plasma procoagulant phospholipid clotting time and venous thromboembolism risk oleh Cathrine Ramberg, Line Wilsgård, Nadezhda Latysheva, Sigrid K. Brækkan, Kristian Hindberg, Timofey Sovershaev, Omri Snir, John‐Bjarne Hansen

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromsø study

    High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromsø study oleh Erin M. Hald, Sigrid K. Brækkan, Ellisiv B. Mathiesen, Inger Njølstad, Tom Wilsgaard, Jan Brox, John-Bjarne Hansen

    Diterbitkan 2011-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study

    Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study oleh Erin Mathiesen Hald, Maja‐Lisa Løchen, Ellisiv B. Mathiesen, Tom Wilsgaard, Inger Njølstad, Sigrid K. Brækkan, John‐Bjarne Hansen

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: